UoN’s USAID Fahari ya Jamii project took part in the Nairobi accelerated COVID-19 vaccination campaign launch at Kibra Level 3 Hospital on Thursday, 2nd June 2022. The campaign targets to have at least 70% of the population in Nairobi vaccinated in the next six weeks. Currently, 48.9% (1,492,877) of the population in Nairobi is fully vaccinated against a targeted population of 3,052,494 persons.
Research scientists from the University of Nairobi have teamed up with their colleagues from other African countries to form the Sisulu Foundation for African and Pandemic Disease Response (The Sisulu Foundation).
Safety concerns, need for more information, fear of side effects, lack of trust in the government or the vaccine, short duration that vaccine development has taken and concerns on efficacy are the attributes to COVID-19 vaccine hesitancy among healthcare workers in Kenya.
According to an online survey conducted by researchers from the University of Nairobi, College of Health Sciences, there is need for deeper engagement through health facility platforms and professional associations to address specific fears and questions on the vaccine by the healthcare workers.
The University Health Services has now been registered as a COVID-19 Vaccination Centre by the Ministry of Health and the Nairobi County Government, through the Nairobi Metropolitan Services.
The Vaccination will commence on Thursday April 8, 2021 at 8.30AM outside of the Main Students Clinic. It should be noted that the University Vaccination Centre will be required to observe Government prioritization guidelines and to comply with COVID-19 health protocols. In this regard, the following categories of the priority target groups will be eligible:
There are high hopes COVID-19 vaccines will help end the pandemic. However, there have been claims about these vaccines that have received mixed reactions from all quarters some advocating for the vaccines and others heavily criticizing the vaccines based on the manner in which the vaccines were hurriedly developed and approved raising safety and effectiveness concerns.
Medical experts from the University of Nairobi (UoN) are set to conduct clinical trials for three possible coronavirus disease (COVID-19) drugs.
The novel coronavirus disease (COVID-19) that has so far infected 2,996,614 people and killed 207,023 others globally continues to pose a great danger to human life.
